Paradigm Biopharmaceuticals | PAR - Operating Profit

Stock Price
0.31
Daily Change
0.01 1.67%
Monthly
-15.28%
Yearly
-36.46%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD-8.5M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Avita Medical AUD -11.15M 1.19M Jun/2025
Medical Developments International AUD -480K 662K Jun/2025
Neuren Pharmaceuticals AUD 5.45M 171.24M Jun/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
PYC Therapeutics AUD -13.47M 12.42M Jun/2025
Telix Pharmaceuticals AUD 17.72M 24.27M Dec/2024